Trial-related deaths in poor countries
BAYER is carrying out an ever increasing number of dangerous drug trials in poor countries, because they offer a large reservoir of test subjects, low prices, fast procedures and little supervision by the authorities. In India alone, there have been at least 138 fatalities as a result of BAYER‚s drug trials on humans in the last four years. The Board of Management bears responsibility for this.
=> April 2013: Countermotion to Bayer Shareholder Meeting
=> Xarelto: BAYER pays compensation in China
=> July 2012: Novartis, Bayer named in Indian trial death list
=> Open letter to the BAYER board
=> Coalition introduces Countermotion to Bayer Shareholder Meeting
=> Lancet: Regulation failing to keep up with Indias trials boom
=> The clinical trial scenario in India
=> The Independent: How drugs companies exploit Indian ‘guinea pigs’
=> MSNBC: In India, oversight lacking in outsourced drug trials